Intrinsic Value

The intrinsic value of Taiko Pharmaceutical Co Ltd (4574) under the Base Case is 199.69 JPY per share. Compared with the current market price of 258 JPY, the stock appears Overvalued by 23% .

The intrinsic value is calculated using the DCF method. The model assumes revenue returns to growth: about 2% a year over the next five years, after falling about 18% a year over the last five years. If revenue grew at its five-year pace of -18%, the estimate would be about ¥71.

Do our valuations actually work? See backtest results .

Intrinsic Value
¥199.69
Overvaluation 23%
Intrinsic Value
Price ¥258
Alert me when Taiko Pharmaceutical Co Ltd is below its intrinsic value
Today ¥159.75 · 38.1% below the current price

Taiko Pharmaceutical Co Ltd is cheaper than usual. Still overvalued, but less so than on more than 99% of days in the past 5 years.

Alternatives to Taiko Pharmaceutical Co Ltd

Fundamental Analysis

What Taiko Pharmaceutical Does

Health Care

Taiko Pharmaceutical Co Ltd makes and sells medicines and health-related products in Japan. Its business is built around over-the-counter drugs, prescription-related items, and other products such as topical treatments and health foods. The company earns money by selling these products through pharmacies, drugstores, medical channels, and other retail and wholesale routes.

Headquarters
Japan JP
Employees
220
IPO date
Mar 18, 2009
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Taiko Pharmaceutical Co Ltd

Wall St Price Targets

Shareholder Returns

Competitive Landscape

Continue Research

Decided on Taiko Pharmaceutical? Get an email when Taiko Pharmaceutical Co Ltd reaches the price you’d buy at. Free with an account.

What is the Intrinsic Value of one Taiko Pharmaceutical Co Ltd stock?

The intrinsic value for Taiko Pharmaceutical Co Ltd (4574) under the Base Case is 199.69 JPY.

Is Taiko Pharmaceutical Co Ltd stock undervalued or overvalued?

Compared with the current market price of 258 JPY, the stock appears Overvalued by 23% .

How reliable are our estimates? See how past valuations played out
Back to Top